Search
Filter by content type
Filter by content year
Filter by category
BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of BioNTech’s BNT162 mRNA-based Vaccine Candidate Against SARS-CoV-2 to Hong Kong SAR and Macao SAR
August 27, 2020 - … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR … BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of … SARS-CoV-2 to Hong Kong SAR and Macao SAR BioNTech and Fosun Pharma to Potentially Supply 10 Million Doses of …